プロテインAレジン市場:製品(アガロースベース、ガラス/シリカベース、有機ポリマーベース)、タイプ(リコンビナントプロテインA、ナチュラルプロテインA)、アプリケーション(抗体精製、免疫沈降)、エンドユーザー&地域別 - 2028年までの世界予測Protein A Resin Market by Product (Agarose-based, Glass/Silica-based, Organic polymer-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), End User & Region - Global Forecast to 2028 プロテインA樹脂の世界市場は、2022年の12億米ドルから2028年には21億米ドルに達し、予測期間中にCAGR 9.8%で成長すると予測されます。治療薬に使用されるプロテインA樹脂の利点の増加は、予測される数年間の市場... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリープロテインA樹脂の世界市場は、2022年の12億米ドルから2028年には21億米ドルに達し、予測期間中にCAGR 9.8%で成長すると予測されます。治療薬に使用されるプロテインA樹脂の利点の増加は、予測される数年間の市場成長を後押しする主要な要因の1つであると予想されます。"2022年、アガロースベースのプロテインA樹脂分野が市場最大シェアを占める" アガロースは、タンパク質と結合するリガンドの付着に最も広く使用されているマトリックス樹脂であるため、2022年にはアガロースベースのプロテインA樹脂市場が最大のシェアを占めています。 "2022年、リコンビナントプロテインA樹脂分野が市場最大シェアを占める" タイプ別では、プロテインA樹脂市場は、組み換えプロテインA樹脂と天然プロテインA樹脂に区分されます。2022年の市場シェアは組換えプロテインA分野が大きく、予測期間中はより高いCAGRを記録すると推定されます。このセグメントの高成長は、創薬や抗体精製のための技術進歩が進んでいることに起因すると考えられます。 "抗体精製分野は予測期間中に最も高いCAGRを記録すると予測される" アプリケーションに基づき、プロテインA樹脂市場は抗体精製と免疫沈降に区分されます。抗体精製アプリケーションセグメントは2022年に市場を支配し、予測期間中に高いCAGRを記録することが予想されます。このセグメントの高い成長は、主に、抗体の下流処理における使用の増加、治療目的だけでなく研究目的でもmAbの需要が増加していることに起因していると考えられます。 "製薬・バイオ医薬品企業セグメントは、予測期間中に最も高いCAGRを記録すると予測される" エンドユーザー市場は、製薬・バイオ医薬品企業、学術研究機関、その他のエンドユーザーに区分されます。2022年の世界のプロテインA樹脂市場では、製薬・バイオ製薬会社が最大のシェアを占めています。また、このエンドユーザー分野は、予測期間中に最も高いCAGRで成長すると推定されます。これは、腫瘍、結核、自己免疫疾患などの異なる疾患の治療領域でモノクローナル抗体の使用が増加していることなどの要因に起因しています。 "2022年、北米地域の市場がプロテインA樹脂の大きな市場シェアを占めると予想される。" プロテインA樹脂市場は、北米、欧州、アジア太平洋、中南米、中東・アフリカの5つの主要地域をカバーしています。北米地域の市場は、2022年にプロテインA樹脂の重要な市場シェアを占めると予想されています。この地域におけるプロテインA樹脂市場の成長は、医薬品の研究開発への投資の増加や、研究開発活動への政府からの資金援助に起因していると思われます。 本レポートで参照した主な参加者の内訳は以下のとおりです: - 企業タイプ別ティア1-48%、ティア2-36%、ティア3-16%:ティア1-48%、ティア2-36%、ティア3-16%。 - 役職別Cレベル-10%、ディレクターレベル-14%、その他-76 - 地域別北米40%、欧州32%、アジア太平洋20%、中南米5%、中近東・アフリカ3%。 プロテインA樹脂市場の著名なプレーヤーは、Danaher Corporation(米国)、Merck KGaA(ドイツ)、Repligen Corporation(米国)、Bio-Rad Laboratories, Inc(米国)、Thermo Fisher Scientific Inc(米国)、Tosoh Corporation(日本)などです。 調査対象 本レポートでは、プロテインA樹脂の市場を製品、タイプ、用途、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、ミクロ市場を個々の成長動向に関して分析し、主要5地域(およびこれらの地域のそれぞれの国)に関して、市場セグメントの収益を予測しています。 レポート購入の理由 本レポートは、C4ISR市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、本市場のマーケットリーダー/新規参入者の助けとなります。本レポートは、関係者が競争環境を理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。 本レポートは、以下のポイントに関する洞察を提供します: - 主要な推進要因(意思決定を支援する統合状況認識の強化ニーズ、非対称戦の脅威に対処するための防衛能力の近代化、無線接続と技術に対する軍事的関心の高まり)、阻害要因(C4システムの高い開発・保守コスト、サイバー攻撃への脆弱性。技術移転に関連する規制上の障害)、機会(軍事機器/技術間の相互運用性の必要性の高まり。C4ISR市場の成長に影響を与える課題(効果的な意思決定を支援するAIの利用拡大、C4ISR向けクラウドコンピューティングおよびデータストレージソリューション)、および課題(多様な脅威に対処する既存の電子戦システムの無力さ)。 - 製品開発/イノベーション:C4ISR市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な考察 - 市場開拓:有利な市場に関する包括的な情報 - 当レポートでは、さまざまな地域のC4ISR市場を分析しています。 - 市場の多様化:C4ISR市場における新製品・サービス、未開拓地域、最新動向、投資に関する情報を網羅的に提供 - 競争力のある評価:C4ISR市場におけるLockheed Martin Corporation(米国)、Raytheon Technologies Corporation(米国)、Thales(フランス)、BAE Systems Inc(英国)、General Dynamics Corporation(米国)、Northrop Grumman(米国)などの主要企業の市場シェア、成長戦略、サービス提供などを詳細に評価します。 - 製品開発/イノベーション:プロテインA樹脂市場の今後の動向、研究開発活動、製品発表に関する詳細な洞察 - 市場開拓:有利な新興地域に関する包括的な情報 - 市場の多様化:プロテインA樹脂市場の新製品、成長地域、最新動向を網羅的に紹介 - 競合他社の評価:主要市場プレイヤーの市場セグメント、成長戦略、収益分析、製品に関する詳細な評価。 目次1 INTRODUCTION 181.1 STUDY OBJECTIVES 18 1.2 MARKET DEFINITION 18 1.3 INCLUSIONS AND EXCLUSIONS 19 TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS AND EXCLUSIONS 19 1.4 MARKETS COVERED 19 FIGURE 1 MARKET SEGMENTATION 19 1.4.1 GEOGRAPHIC SEGMENTATION 20 1.5 YEARS CONSIDERED 20 1.6 CURRENCY CONSIDERED 20 1.7 LIMITATIONS 21 1.8 STAKEHOLDERS 21 1.9 SUMMARY OF CHANGES 21 2 RESEARCH METHODOLOGY 23 2.1 RESEARCH DATA 23 2.2 RECESSION IMPACT 23 FIGURE 2 RESEARCH DESIGN 24 2.2.1 SECONDARY RESEARCH 25 2.2.2 PRIMARY RESEARCH 26 2.2.2.1 Primary sources 26 2.2.2.2 Key industry insights 27 2.2.2.3 Breakdown of primaries 27 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 27 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28 2.3 RESEARCH ASSUMPTION 28 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 29 2.3.1 BOTTOM-UP APPROACH 29 2.3.1.1 Approach 1: Company revenue estimation approach 30 FIGURE 6 MARKET SIZE ESTIMATION: VENDOR REVENUE MAPPING APPROACH 30 FIGURE 7 ANALYSIS OF VENDOR REVENUE MAPPING 31 2.3.1.2 Approach 2: Customer-based market estimation 31 FIGURE 8 PROTEIN A RESIN MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32 2.3.1.3 CAGR projection 32 FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 32 2.4 DATA VALIDATION APPROACH 33 FIGURE 10 DATA TRIANGULATION METHODOLOGY 33 2.5 MARKET SHARE ASSESSMENT 34 2.6 STUDY ASSUMPTIONS 34 2.7 RISK ASSESSMENT 34 2.7.1 PROTEIN A RESIN MARKET: RISK ASSESSMENT 34 2.8 GROWTH RATE ASSUMPTIONS 35 3 EXECUTIVE SUMMARY 36 FIGURE 11 PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 36 FIGURE 12 PROTEIN A RESIN MARKET, BY TYPE, 2022 VS. 2028 (USD MILLION) 37 FIGURE 13 PROTEIN A RESIN MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION) 37 FIGURE 14 PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 38 FIGURE 15 GEOGRAPHIC SNAPSHOT: PROTEIN A RESIN MARKET 39 4 PREMIUM INSIGHTS 40 4.1 PROTEIN A RESIN MARKET OVERVIEW 40 FIGURE 16 INCREASING DEMAND FOR PRE-PACKED DISPOSABLE COLUMNS TO DRIVE MARKET GROWTH 40 4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 41 FIGURE 17 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD 41 4.3 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 41 FIGURE 18 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO CONTINUE TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD 41 4.4 GEOGRAPHIC SNAPSHOT OF PROTEIN A RESIN MARKET 42 FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42 5 MARKET OVERVIEW 43 5.1 INTRODUCTION 43 5.2 MARKET DYNAMICS 43 FIGURE 20 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43 5.2.1 DRIVERS 44 5.2.1.1 Growing demand for disposable pre-packed columns 44 TABLE 2 ADVANTAGES OF PRE-PACKED COLUMNS 44 5.2.1.2 Increasing demand for therapeutic antibodies 44 5.2.1.3 Increasing pharmaceutical R&D spending 45 5.2.1.4 Stringent regulatory control in healthcare industry 45 5.2.2 RESTRAINTS 45 5.2.2.1 High cost of resins 45 5.2.2.2 Dearth of skilled professionals 45 5.2.3 OPPORTUNITIES 46 5.2.3.1 Increasing number of CMOs and CROs 46 5.2.4 CHALLENGES 46 5.2.4.1 Regulatory restrictions 46 5.2.4.2 Issues associated with scaling up production of protein A resins 47 5.3 REGULATIONS 47 5.3.1 NORTH AMERICA 47 5.3.1.1 US 47 5.3.1.2 Canada 47 5.3.2 EUROPE 48 5.3.3 ASIA PACIFIC 48 5.3.4 LATIN AMERICA 49 5.3.5 MIDDLE EAST & AFRICA 49 5.4 PRICING ANALYSIS: PROTEIN A RESIN MARKET 49 5.5 PORTER’S FIVE FORCES ANALYSIS 50 TABLE 3 PROTEIN A RESIN MARKET: PORTER’S FIVE FORCES ANALYSIS 50 5.5.1 THREAT OF SUBSTITUTES 50 5.5.2 BARGAINING POWER OF SUPPLIERS 51 5.5.3 BARGAINING POWER OF BUYERS 51 5.5.4 THREAT OF NEW ENTRANTS 52 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 52 6 PROTEIN A RESIN MARKET, BY PRODUCT 53 6.1 INTRODUCTION 54 TABLE 4 PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 54 6.2 AGAROSE-BASED PROTEIN A 54 6.2.1 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE MARKET 54 TABLE 5 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 55 TABLE 6 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55 TABLE 7 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55 TABLE 8 ASIA PACIFIC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 56 6.3 GLASS/SILICA-BASED PROTEIN A 56 6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH 56 TABLE 9 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 56 TABLE 10 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57 TABLE 11 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57 TABLE 12 ASIA PACIFIC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 58 6.4 ORGANIC POLYMER-BASED PROTEIN A 58 6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH 58 TABLE 13 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 59 TABLE 14 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59 TABLE 15 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59 TABLE 16 ASIA PACIFIC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 60 7 PROTEIN A RESIN MARKET, BY TYPE 61 7.1 INTRODUCTION 62 TABLE 17 PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 62 7.2 RECOMBINANT PROTEIN A 62 7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH 62 TABLE 18 RECOMBINANT PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63 7.3 NATURAL PROTEIN A 63 7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED MARKET POTENTIAL OF NATURAL PROTEIN A 63 TABLE 19 NATURAL PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63 8 PROTEIN A RESIN MARKET, BY APPLICATION 64 8.1 INTRODUCTION 65 TABLE 20 PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 65 8.2 ANTIBODY PURIFICATION 65 8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 65 TABLE 21 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2020–2028 (USD MILLION) 66 8.3 IMMUNOPRECIPITATION 66 8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT LOWER CAGR DURING FORECAST PERIOD 66 TABLE 22 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2020–2028 (USD MILLION) 66 9 PROTEIN A RESIN MARKET, BY END USER 67 9.1 INTRODUCTION 68 TABLE 23 PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 68 9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 68 9.2.1 PROTEIN A RESINS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS 68 FIGURE 21 SPENDING ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, 2020–2028 (USD BILLION) 69 TABLE 24 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2028 (USD MILLION) 69 9.3 ACADEMIC RESEARCH INSTITUTES 70 9.3.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF PROTEIN A RESINS 70 TABLE 25 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2028 (USD MILLION) 70 9.4 OTHER END USERS 70 TABLE 26 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2020–2028 (USD MILLION) 71 10 PROTEIN A RESIN MARKET, BY REGION 72 10.1 INTRODUCTION 73 TABLE 27 PROTEIN A RESIN MARKET, BY REGION, 2020–2028 (USD MILLION) 73 10.2 NORTH AMERICA 74 FIGURE 22 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT 74 TABLE 28 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 75 TABLE 29 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 75 TABLE 30 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 75 TABLE 31 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 76 TABLE 32 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 76 10.2.1 US 76 10.2.1.1 Increasing R&D investments in pharmaceutical industry to propel market growth 76 TABLE 33 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77 10.2.2 CANADA 77 10.2.2.1 Government initiatives focused on boosting pharmaceutical industry to drive market growth 77 TABLE 34 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77 10.3 EUROPE 78 TABLE 35 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 78 TABLE 36 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 78 TABLE 37 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 79 TABLE 38 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 79 TABLE 39 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 79 10.3.1 GERMANY 80 10.3.1.1 Flourishing biotechnology industry to drive market growth 80 TABLE 40 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 80 10.3.2 UK 80 10.3.2.1 Favorable R&D scenario to support market growth 80 TABLE 41 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81 10.3.3 FRANCE 81 10.3.3.1 Favorable healthcare scenario to boost market growth 81 TABLE 42 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81 10.3.4 ITALY 82 10.3.4.1 Well-established pharmaceutical industry to spur demand for protein A resins 82 TABLE 43 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 82 10.3.5 SPAIN 82 10.3.5.1 Presence of large number of biotech R&D service providers to support market growth 82 TABLE 44 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 83 10.3.6 REST OF EUROPE 83 TABLE 45 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 84 10.4 ASIA PACIFIC 85 FIGURE 23 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT 85 TABLE 46 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 86 TABLE 47 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 86 TABLE 48 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 86 TABLE 49 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 87 TABLE 50 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 87 10.4.1 JAPAN 87 10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption 87 TABLE 51 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88 10.4.2 CHINA 88 10.4.2.1 Increasing pharmaceutical R&D spending to drive market growth 88 TABLE 52 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88 10.4.3 INDIA 89 10.4.3.1 Growth of pharma and biotech industries to drive demand for protein A resins 89 TABLE 53 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 89 10.4.4 AUSTRALIA 89 10.4.4.1 Increasing demand for protein-based therapeutics for treatment of infectious diseases to drive growth 89 TABLE 54 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90 10.4.5 SOUTH KOREA 90 10.4.5.1 Developments in biopharmaceutical sector to drive market growth 90 TABLE 55 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90 10.4.6 REST OF ASIA PACIFIC 91 TABLE 56 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 91 10.5 REST OF THE WORLD 91 TABLE 57 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 92 TABLE 58 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 92 TABLE 59 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 92 TABLE 60 ROW: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 93 11 COMPETITIVE LANDSCAPE 94 11.1 OVERVIEW 94 11.2 MARKET SHARE ANALYSIS 94 FIGURE 24 PROTEIN A RESIN MARKET SHARE ANALYSIS (2021) 94 11.3 COMPETITIVE LEADERSHIP MAPPING 95 11.3.1 STARS 95 11.3.2 EMERGING LEADERS 95 11.3.3 PERVASIVE PLAYERS 95 11.3.4 PARTICIPANTS 95 FIGURE 25 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2022) 96 11.4 COMPETITIVE SCENARIO 97 11.4.1 PRODUCT LAUNCHES 97 TABLE 61 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO FEBRUARY 2023 97 11.4.2 DEALS 97 TABLE 62 PROTEIN A RESIN MARKET: DEALS, JANUARY 2020 TO FEBRUARY 2023 97 11.4.3 OTHER DEVELOPMENTS 98 TABLE 63 PROTEIN A RESIN MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO FEBRUARY 2023 98 12 COMPANY PROFILES 99 12.1 KEY PLAYERS 99 (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)* 12.1.1 DANAHER CORPORATION 99 TABLE 64 DANAHER CORPORATION: COMPANY OVERVIEW 99 FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 100 12.1.2 THERMO FISHER SCIENTIFIC 103 TABLE 65 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 103 FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 104 12.1.3 MERCK KGAA 107 TABLE 66 MERCK KGAA: COMPANY OVERVIEW 107 FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2022) 108 12.1.4 REPLIGEN CORPORATION 110 TABLE 67 REPLIGEN CORPORATION: COMPANY OVERVIEW 110 FIGURE 29 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022) 110 12.1.5 TOSOH BIOSCIENCE LLC 113 TABLE 68 TOSOH BIOSCIENCE LLC: COMPANY OVERVIEW 113 FIGURE 30 TOSOH BIOSCIENCE LLC: COMPANY SNAPSHOT (2021) 114 12.1.6 AGILENT TECHNOLOGIES, INC. 116 TABLE 69 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 116 FIGURE 31 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2022) 117 12.1.7 PUROLITE 120 TABLE 70 PUROLITE: COMPANY OVERVIEW 120 12.1.8 PERKINELMER INC. 122 TABLE 71 PERKINELMER INC.: COMPANY OVERVIEW 122 FIGURE 32 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 123 12.1.9 NOVASEP HOLDING SAS 124 TABLE 72 NOVASEP HOLDING SAS: COMPANY OVERVIEW 124 12.1.10 GENSCRIPT 125 TABLE 73 GENSCRIPT: COMPANY OVERVIEW 125 FIGURE 33 GENSCRIPT: COMPANY SNAPSHOT (2021) 126 12.1.11 BIO-RAD LABORATORIES, INC. 127 TABLE 74 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 127 FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 128 12.1.12 KANEKA CORPORATION 130 TABLE 75 KANEKA CORPORATION: COMPANY OVERVIEW 130 FIGURE 35 KANEKA CORPORATION: COMPANY SNAPSHOT (2021) 130 12.1.13 OROCHEM TECHNOLOGIES INC. 132 TABLE 76 OROCHEM TECHNOLOGIES INC.: COMPANY OVERVIEW 132 12.1.14 ABCAM PLC 133 TABLE 77 ABCAM PLC.: COMPANY OVERVIEW 133 12.1.15 AGAROSE BEAD TECHNOLOGIES 134 TABLE 78 AGAROSE BEAD TECHNOLOGIES: COMPANY OVERVIEW 134 *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies. 12.2 OTHER COMPANIES 135 12.2.1 AVANTOR, INC. 135 12.2.2 JSR LIFESCIENCES, LLC 135 12.2.3 BIO-WORKS 136 12.2.4 TAKARA BIO INC. 136 12.2.5 GENERON 137 12.2.6 GENO TECHNOLOGY INC. 137 12.2.7 JNC CORPORATION 138 12.2.8 PROMEGA CORPORATION 138 12.2.9 SUZHOU NANOMICRO TECHNOLOGY CO., LTD. 139 12.2.10 TRANSGEN BIOTECH CO., LTD. 139 13 APPENDIX 140 13.1 DISCUSSION GUIDE 140 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143 13.3 CUSTOMIZATION OPTIONS 145 13.4 RELATED REPORTS 145 13.5 AUTHOR DETAILS 147
SummaryThe global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. The rise in advantages offered by protein A resin to be used in therapeutics is one of the major factors anticipated to boost market growth in the forecasting years. Table of Contents1 INTRODUCTION 181.1 STUDY OBJECTIVES 18 1.2 MARKET DEFINITION 18 1.3 INCLUSIONS AND EXCLUSIONS 19 TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS AND EXCLUSIONS 19 1.4 MARKETS COVERED 19 FIGURE 1 MARKET SEGMENTATION 19 1.4.1 GEOGRAPHIC SEGMENTATION 20 1.5 YEARS CONSIDERED 20 1.6 CURRENCY CONSIDERED 20 1.7 LIMITATIONS 21 1.8 STAKEHOLDERS 21 1.9 SUMMARY OF CHANGES 21 2 RESEARCH METHODOLOGY 23 2.1 RESEARCH DATA 23 2.2 RECESSION IMPACT 23 FIGURE 2 RESEARCH DESIGN 24 2.2.1 SECONDARY RESEARCH 25 2.2.2 PRIMARY RESEARCH 26 2.2.2.1 Primary sources 26 2.2.2.2 Key industry insights 27 2.2.2.3 Breakdown of primaries 27 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 27 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28 2.3 RESEARCH ASSUMPTION 28 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 29 2.3.1 BOTTOM-UP APPROACH 29 2.3.1.1 Approach 1: Company revenue estimation approach 30 FIGURE 6 MARKET SIZE ESTIMATION: VENDOR REVENUE MAPPING APPROACH 30 FIGURE 7 ANALYSIS OF VENDOR REVENUE MAPPING 31 2.3.1.2 Approach 2: Customer-based market estimation 31 FIGURE 8 PROTEIN A RESIN MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32 2.3.1.3 CAGR projection 32 FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 32 2.4 DATA VALIDATION APPROACH 33 FIGURE 10 DATA TRIANGULATION METHODOLOGY 33 2.5 MARKET SHARE ASSESSMENT 34 2.6 STUDY ASSUMPTIONS 34 2.7 RISK ASSESSMENT 34 2.7.1 PROTEIN A RESIN MARKET: RISK ASSESSMENT 34 2.8 GROWTH RATE ASSUMPTIONS 35 3 EXECUTIVE SUMMARY 36 FIGURE 11 PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 36 FIGURE 12 PROTEIN A RESIN MARKET, BY TYPE, 2022 VS. 2028 (USD MILLION) 37 FIGURE 13 PROTEIN A RESIN MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION) 37 FIGURE 14 PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 38 FIGURE 15 GEOGRAPHIC SNAPSHOT: PROTEIN A RESIN MARKET 39 4 PREMIUM INSIGHTS 40 4.1 PROTEIN A RESIN MARKET OVERVIEW 40 FIGURE 16 INCREASING DEMAND FOR PRE-PACKED DISPOSABLE COLUMNS TO DRIVE MARKET GROWTH 40 4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 41 FIGURE 17 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD 41 4.3 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 41 FIGURE 18 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO CONTINUE TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD 41 4.4 GEOGRAPHIC SNAPSHOT OF PROTEIN A RESIN MARKET 42 FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42 5 MARKET OVERVIEW 43 5.1 INTRODUCTION 43 5.2 MARKET DYNAMICS 43 FIGURE 20 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43 5.2.1 DRIVERS 44 5.2.1.1 Growing demand for disposable pre-packed columns 44 TABLE 2 ADVANTAGES OF PRE-PACKED COLUMNS 44 5.2.1.2 Increasing demand for therapeutic antibodies 44 5.2.1.3 Increasing pharmaceutical R&D spending 45 5.2.1.4 Stringent regulatory control in healthcare industry 45 5.2.2 RESTRAINTS 45 5.2.2.1 High cost of resins 45 5.2.2.2 Dearth of skilled professionals 45 5.2.3 OPPORTUNITIES 46 5.2.3.1 Increasing number of CMOs and CROs 46 5.2.4 CHALLENGES 46 5.2.4.1 Regulatory restrictions 46 5.2.4.2 Issues associated with scaling up production of protein A resins 47 5.3 REGULATIONS 47 5.3.1 NORTH AMERICA 47 5.3.1.1 US 47 5.3.1.2 Canada 47 5.3.2 EUROPE 48 5.3.3 ASIA PACIFIC 48 5.3.4 LATIN AMERICA 49 5.3.5 MIDDLE EAST & AFRICA 49 5.4 PRICING ANALYSIS: PROTEIN A RESIN MARKET 49 5.5 PORTER’S FIVE FORCES ANALYSIS 50 TABLE 3 PROTEIN A RESIN MARKET: PORTER’S FIVE FORCES ANALYSIS 50 5.5.1 THREAT OF SUBSTITUTES 50 5.5.2 BARGAINING POWER OF SUPPLIERS 51 5.5.3 BARGAINING POWER OF BUYERS 51 5.5.4 THREAT OF NEW ENTRANTS 52 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 52 6 PROTEIN A RESIN MARKET, BY PRODUCT 53 6.1 INTRODUCTION 54 TABLE 4 PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 54 6.2 AGAROSE-BASED PROTEIN A 54 6.2.1 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE MARKET 54 TABLE 5 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 55 TABLE 6 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55 TABLE 7 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55 TABLE 8 ASIA PACIFIC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 56 6.3 GLASS/SILICA-BASED PROTEIN A 56 6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH 56 TABLE 9 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 56 TABLE 10 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57 TABLE 11 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57 TABLE 12 ASIA PACIFIC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 58 6.4 ORGANIC POLYMER-BASED PROTEIN A 58 6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH 58 TABLE 13 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 59 TABLE 14 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59 TABLE 15 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59 TABLE 16 ASIA PACIFIC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 60 7 PROTEIN A RESIN MARKET, BY TYPE 61 7.1 INTRODUCTION 62 TABLE 17 PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 62 7.2 RECOMBINANT PROTEIN A 62 7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH 62 TABLE 18 RECOMBINANT PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63 7.3 NATURAL PROTEIN A 63 7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED MARKET POTENTIAL OF NATURAL PROTEIN A 63 TABLE 19 NATURAL PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63 8 PROTEIN A RESIN MARKET, BY APPLICATION 64 8.1 INTRODUCTION 65 TABLE 20 PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 65 8.2 ANTIBODY PURIFICATION 65 8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 65 TABLE 21 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2020–2028 (USD MILLION) 66 8.3 IMMUNOPRECIPITATION 66 8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT LOWER CAGR DURING FORECAST PERIOD 66 TABLE 22 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2020–2028 (USD MILLION) 66 9 PROTEIN A RESIN MARKET, BY END USER 67 9.1 INTRODUCTION 68 TABLE 23 PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 68 9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 68 9.2.1 PROTEIN A RESINS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS 68 FIGURE 21 SPENDING ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, 2020–2028 (USD BILLION) 69 TABLE 24 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2028 (USD MILLION) 69 9.3 ACADEMIC RESEARCH INSTITUTES 70 9.3.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF PROTEIN A RESINS 70 TABLE 25 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2028 (USD MILLION) 70 9.4 OTHER END USERS 70 TABLE 26 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2020–2028 (USD MILLION) 71 10 PROTEIN A RESIN MARKET, BY REGION 72 10.1 INTRODUCTION 73 TABLE 27 PROTEIN A RESIN MARKET, BY REGION, 2020–2028 (USD MILLION) 73 10.2 NORTH AMERICA 74 FIGURE 22 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT 74 TABLE 28 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 75 TABLE 29 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 75 TABLE 30 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 75 TABLE 31 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 76 TABLE 32 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 76 10.2.1 US 76 10.2.1.1 Increasing R&D investments in pharmaceutical industry to propel market growth 76 TABLE 33 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77 10.2.2 CANADA 77 10.2.2.1 Government initiatives focused on boosting pharmaceutical industry to drive market growth 77 TABLE 34 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77 10.3 EUROPE 78 TABLE 35 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 78 TABLE 36 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 78 TABLE 37 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 79 TABLE 38 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 79 TABLE 39 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 79 10.3.1 GERMANY 80 10.3.1.1 Flourishing biotechnology industry to drive market growth 80 TABLE 40 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 80 10.3.2 UK 80 10.3.2.1 Favorable R&D scenario to support market growth 80 TABLE 41 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81 10.3.3 FRANCE 81 10.3.3.1 Favorable healthcare scenario to boost market growth 81 TABLE 42 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81 10.3.4 ITALY 82 10.3.4.1 Well-established pharmaceutical industry to spur demand for protein A resins 82 TABLE 43 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 82 10.3.5 SPAIN 82 10.3.5.1 Presence of large number of biotech R&D service providers to support market growth 82 TABLE 44 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 83 10.3.6 REST OF EUROPE 83 TABLE 45 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 84 10.4 ASIA PACIFIC 85 FIGURE 23 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT 85 TABLE 46 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 86 TABLE 47 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 86 TABLE 48 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 86 TABLE 49 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 87 TABLE 50 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 87 10.4.1 JAPAN 87 10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption 87 TABLE 51 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88 10.4.2 CHINA 88 10.4.2.1 Increasing pharmaceutical R&D spending to drive market growth 88 TABLE 52 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88 10.4.3 INDIA 89 10.4.3.1 Growth of pharma and biotech industries to drive demand for protein A resins 89 TABLE 53 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 89 10.4.4 AUSTRALIA 89 10.4.4.1 Increasing demand for protein-based therapeutics for treatment of infectious diseases to drive growth 89 TABLE 54 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90 10.4.5 SOUTH KOREA 90 10.4.5.1 Developments in biopharmaceutical sector to drive market growth 90 TABLE 55 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90 10.4.6 REST OF ASIA PACIFIC 91 TABLE 56 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 91 10.5 REST OF THE WORLD 91 TABLE 57 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 92 TABLE 58 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 92 TABLE 59 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 92 TABLE 60 ROW: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 93 11 COMPETITIVE LANDSCAPE 94 11.1 OVERVIEW 94 11.2 MARKET SHARE ANALYSIS 94 FIGURE 24 PROTEIN A RESIN MARKET SHARE ANALYSIS (2021) 94 11.3 COMPETITIVE LEADERSHIP MAPPING 95 11.3.1 STARS 95 11.3.2 EMERGING LEADERS 95 11.3.3 PERVASIVE PLAYERS 95 11.3.4 PARTICIPANTS 95 FIGURE 25 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2022) 96 11.4 COMPETITIVE SCENARIO 97 11.4.1 PRODUCT LAUNCHES 97 TABLE 61 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO FEBRUARY 2023 97 11.4.2 DEALS 97 TABLE 62 PROTEIN A RESIN MARKET: DEALS, JANUARY 2020 TO FEBRUARY 2023 97 11.4.3 OTHER DEVELOPMENTS 98 TABLE 63 PROTEIN A RESIN MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO FEBRUARY 2023 98 12 COMPANY PROFILES 99 12.1 KEY PLAYERS 99 (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)* 12.1.1 DANAHER CORPORATION 99 TABLE 64 DANAHER CORPORATION: COMPANY OVERVIEW 99 FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 100 12.1.2 THERMO FISHER SCIENTIFIC 103 TABLE 65 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 103 FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 104 12.1.3 MERCK KGAA 107 TABLE 66 MERCK KGAA: COMPANY OVERVIEW 107 FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2022) 108 12.1.4 REPLIGEN CORPORATION 110 TABLE 67 REPLIGEN CORPORATION: COMPANY OVERVIEW 110 FIGURE 29 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022) 110 12.1.5 TOSOH BIOSCIENCE LLC 113 TABLE 68 TOSOH BIOSCIENCE LLC: COMPANY OVERVIEW 113 FIGURE 30 TOSOH BIOSCIENCE LLC: COMPANY SNAPSHOT (2021) 114 12.1.6 AGILENT TECHNOLOGIES, INC. 116 TABLE 69 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 116 FIGURE 31 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2022) 117 12.1.7 PUROLITE 120 TABLE 70 PUROLITE: COMPANY OVERVIEW 120 12.1.8 PERKINELMER INC. 122 TABLE 71 PERKINELMER INC.: COMPANY OVERVIEW 122 FIGURE 32 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 123 12.1.9 NOVASEP HOLDING SAS 124 TABLE 72 NOVASEP HOLDING SAS: COMPANY OVERVIEW 124 12.1.10 GENSCRIPT 125 TABLE 73 GENSCRIPT: COMPANY OVERVIEW 125 FIGURE 33 GENSCRIPT: COMPANY SNAPSHOT (2021) 126 12.1.11 BIO-RAD LABORATORIES, INC. 127 TABLE 74 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 127 FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 128 12.1.12 KANEKA CORPORATION 130 TABLE 75 KANEKA CORPORATION: COMPANY OVERVIEW 130 FIGURE 35 KANEKA CORPORATION: COMPANY SNAPSHOT (2021) 130 12.1.13 OROCHEM TECHNOLOGIES INC. 132 TABLE 76 OROCHEM TECHNOLOGIES INC.: COMPANY OVERVIEW 132 12.1.14 ABCAM PLC 133 TABLE 77 ABCAM PLC.: COMPANY OVERVIEW 133 12.1.15 AGAROSE BEAD TECHNOLOGIES 134 TABLE 78 AGAROSE BEAD TECHNOLOGIES: COMPANY OVERVIEW 134 *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies. 12.2 OTHER COMPANIES 135 12.2.1 AVANTOR, INC. 135 12.2.2 JSR LIFESCIENCES, LLC 135 12.2.3 BIO-WORKS 136 12.2.4 TAKARA BIO INC. 136 12.2.5 GENERON 137 12.2.6 GENO TECHNOLOGY INC. 137 12.2.7 JNC CORPORATION 138 12.2.8 PROMEGA CORPORATION 138 12.2.9 SUZHOU NANOMICRO TECHNOLOGY CO., LTD. 139 12.2.10 TRANSGEN BIOTECH CO., LTD. 139 13 APPENDIX 140 13.1 DISCUSSION GUIDE 140 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143 13.3 CUSTOMIZATION OPTIONS 145 13.4 RELATED REPORTS 145 13.5 AUTHOR DETAILS 147
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(産業機械)の最新刊レポート
MarketsandMarkets社のAnalytical and Scientific Instrumentation分野での最新刊レポート
本レポートと同じKEY WORD(antibody)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |